Nephrotic syndrome and mizoribine in children

Pediatrics International

Volumn 44, Issue 2, 2002, Pages 210-216

  Honda, Masataka ^a  

^a Tokyo Metropolitan Kiyose Children's Hospital   (Japan)

Author keywords

Immunosuppressant children; Mizoribine; Nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PUROMYCIN AMINONUCLEOSIDE; STEROID;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

ANIMALS; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; RECURRENCE; RIBONUCLEOSIDES;

EID: 0036122448     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1328-8067.2001.01533.x     Document Type: Review

References (22)

1. Nephrotic syndrome in children: Prediction of histopathology from clinical andlaboratory characteristics at time of diagnosis
2. Steroid responsive nephrotic syndome
3. Drug therapy in children with primary nephrotic syndome
4. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerular sclerosis
5. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparision of eight weeks with twelve week course
6. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmentalglomerulosclerosis
7. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulsemethylprednisolone and alkylating agents
8. Low dose cyclosporin, mizoribine, and prednisolone in renal transplantation: A new triple therapy
9. Mizoribine and mycophenolate moefil
10. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside
11. Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children
12. Mizoribine in steroid-dependent nephrotic syndrome of childhood
13. The effect of mizoribine in children with frequent relapsing nephrotic syndrome
14. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome
15. Clinical evaluation of immunosuppressive drug, mizoribine on steroid-resistant nephrotic syndrome: A muliticenter double-blind comparison study with placebo
16. Trends in immunosuppressive therapy: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
17. U.S. Renal Transplant Study Group: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
18. A blinded, randomized mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
19. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil
20. Ciclosporin treatment in children with steroid-dependent nephrotic syndrome
21. Cyclosporin versus cyclophosphamide for patient with steroid-dependent and frequently relapsing relapsing idiopathic nephrotic syndrome: A multicenter randomized controlled trial
22. Cyclosporin treatment in children with steroid-dependent nephrotic syndrome